Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 10

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 10
---
: | What percentage of our outstanding common stock do our directors and executive officers own? |

| Q: | Who is paying for this proxy solicitation? |

| A. | We will pay the entire cost of preparing, assembling, printing, mailing, and distributing these proxy materials and soliciting votes.  If you choose to vote over the internet, you are responsible for internet access charges you may incur.  If you choose to vote by telephone, you are responsible for telephone charges you may incur.  In addition to the mailing of these proxy materials, the solicitation of proxies or votes may be made in person, by telephone or by electronic communication by our directors, officers and employees, who will not receive any additional compensation for such solicitation activities.  Proxies also may be solicited by employees and our directors by mail, telephone, facsimile, e-mail or in person. |

| Q: | How can I obtain a copy of our Annual Report on Form 10-K? |

5

CORPORATE GOVERNANCE Our Board of Directors Our Bylaws provide that our board of directors (the “Board”) shall consist of between one and nine directors, and such number of directors within this range may be determined from time to time by resolution of our Board or our stockholders. Currently, we have seven directors. The following individuals are being nominated to serve on our Board (See “ Proposal 1 - Election of Directors; Nominees”):

|                            |   |     |   |                                                                                  | ​ |                | ​ | ​ | ​ |
| Name                       |   | Age |   | Position(s)                                                                      | ​ | Director Since | ​ | ​ | ​ |
| Manuel Litchman, M.D.      |   |  71 |   | President, Chief Executive Officer, Interim Chief Financial Officer and Director | ​ |           2017 | ​ | ​ | ​ |
| Michael S. Weiss           |   |  59 |   | Chairman of the Board of Directors and Executive Chairman                        | ​ |           2015 | ​ | ​ | ​ |
| Adam J. Chill              |   |  57 |   | Director                                                                         | ​ |           2017 | ​ | ​ | ​ |
| Neil Herskowitz            |   |  68 |   | Director                                                                         | ​ |           2015 | ​ | ​ | ​ |
| David Jin                  | ​ |  35 | ​ | Director                                                                         | ​ |           2024